Fluid Therapy in Dogs and Cats With Sepsis

19 de março de 2021

Fluidoterapia em cães e gatos com sepse

Autores

Federico Montealegre, Bridget M. Lyons

Abstract

Sepsis is currently defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis may occur secondary to infection anywhere in the body, and its pathogenesis is complex and not yet fully understood. Variations in the host immune response result in diverse clinical manifestations, which complicates clinical recognition and fluid therapy both in humans and veterinary species. Septic shock is a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone. Although septic shock is a form of distributive shock, septic patients frequently present with hypovolemic and cardiogenic shock as well, further complicating fluid therapy decisions. The goals of this review are to discuss the clinical recognition of sepsis in dogs and cats, the basic mechanisms of its pathogenesis as it affects hemodynamic function, and considerations for fluid therapy. Important pathophysiologic changes, such as cellular interaction, microvascular alterations, damage to the endothelial glycocalyx,
hypoalbuminemia, and immune paralysis will be also reviewed. The advantages and disadvantages of treatment with crystalloids, natural and synthetic colloids, and blood products will be discussed. Current recommendations for evaluating fluid responsiveness and the timing of vasopressor therapy will also be considered. Where available, the veterinary literature will be used to guide recommendations.

Keywords

Sepsis, septic shock (MeSH), fluid therapy, critical care—small animal, immunopathogenesis

Palavras-chave

Sepse, choque séptico (MeSH), fluidoterapia, cuidados intensivos - pequenos animais, imunopatogênese

Comentar este artigo

Você precisa estar logado para comentar os artigos.
Desenvolvido por logo-crowd